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Hybrid carcinoma of the salivary gland: salivary duct adenocarcinoma adenoid
cystic carcinoma
Aims: Hybrid tumours of the salivary gland are rare
neoplasms that have been described only in the parotid
and palate. Their recognition is important particularly
when the component tumours have different biological
behaviours. The occurrence of a submandibular hybrid
tumour has not been reported.
Methods and results: We describe a case of a 36-year-old
woman with a hybrid carcinoma composed of salivary
duct adenocarcinoma and adenoid cystic carcinoma of
the right submandibular gland. There was no evidence
of a pre-existing or concurrent pleomorphic adenoma.
The presence of the two components was verified by
differential immunohistochemical staining using a
panel of cytokeratin, vimentin, smooth muscle actin
and S100. The patient subsequently developed meta-
stases to the pelvis, lumbar, vertebra and wrist. The
clinical course in this patient was consistent with
the behaviour of the salivary duct adenocarcinoma
component.
Conclusions: The histogenesis of hybrid tumours is
largely unknown, but in this case it may represent
diverging differentiation of luminal tumour cells.
Because some histological features of different salivary
gland tumours overlap, immunohistochemistry is a
valuable tool especially when used to delineate the
components of a hybrid tumour.
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Introduction
Hybrid carcinomas of the salivary gland are rare
tumours that contain features of two separate and
distinct tumour lines arising within the same lesion.
Only three cases have been reported thus far in the
English literature, two involving the palate and
the other in the parotid.1,2 We describe the first case
of hybrid carcinoma occurring in the submandibular
gland in a 36-year-old woman. The tumour consisted
of salivary duct carcinoma and adenoid cystic carcin-
oma, with the classic architectural components of
each admixed, as seen histologically and confirmed
immunohistochemically.
Case report
A 36-year-old woman consulted her primary physician
because of a right submandibular mass that had been
present for 1 year. During this time the patient noted
a 40-pound weight loss but was otherwise asympto-
matic. Apart from a 20-pack-year smoking history, her
past medical history was unremarkable. Initial physical
examination revealed no oropharyngeal lesions and
no cervical adenopathy. She underwent excision of the
mass. At the local hospital, the tumour was initially
called an adenoid cystic carcinoma that had extended
to the surgical margins. Re-excision revealed residual
adenoid cystic carcinoma involving bone and soft
tissue. Partial neck dissection revealed 13 lymph nodes
negative for metastases. She was then referred to the
University of Michigan Hospitals for further manage-
ment. She received radiotherapy and on further imag-
ing studies was found to have metastatic disease in the
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pelvis, lumbar region and wrist. The clinical suspicion
of metastases were not confirmed histologically.
PAT H O L O G I C A L F I N D I N G S
The right submandibular gland taken during the initial
resection measured 35 × 25 × 20 mm and was virtually
completely replaced by tumour. The cut surface was
hard and white. Microscopically various architectural
patterns were observed. Peripherally, the classic cribri-
form pattern of adenoid cystic carcinoma was present
(Figure 1). The tumour cells appeared basaloid, with
angular nuclei, small nucleoli, scant eosinophilic cyto-
plasm and indistinct cell borders. The cyst-like spaces
contained pale basophilic material as well as eosino-
philic basal lamina material. About 80% of the tumour,
however, consisted of salivary duct adenocarcinoma.
There were solid nests of pleomorphic cells with central
comedo-type necrosis and occasional dystrophic calci-
fication (Figure 2). Mitotic figures were readily identi-
fied. In addition, small infiltrating cords and ductular
structures within dense fibrosis (Figure 3) and peri-
neural invasion were noted. No vascular invasion was
identified. The tumour did not exhibit features of a pre-
existing or concurrent pleomorphic adenoma.
Sections of formalin-fixed, paraffin-embedded tissue
were stained for high molecular weight cytokeratin (1:5
dilution, Sigma, St. Louis, MO), smooth muscle actin
(1:1600, Sigma), vimentin (1:20, Dako, Carpinteria,
CA), S100 (Dako), oestrogen receptor (ER) (predilute
Ventana Medical Systems) and progesterone receptor
(PR) (1:2, Abbott, Abbott Park, IL) and BRST-2 (1:50,
Signet, Dedham, MA). The salivary duct carcinoma
component was positive for cytokeratin and S100 but
was negative for actin, ER/PR and BRST-2. The inner
layer of the adenoid cystic carcinoma was positive for
only cytokeratin. In contrast, the outer layer was nega-
tive for cytokeratin but positive for actin and vimentin.
Discussion
A hybrid tumour of the salivary gland is composed of
two distinct tumour lines intimately admixed within
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Figure 1. Classic cribriform pattern of adenoid cystic carcinoma.
Figure 2. Salivary duct adenocarcinoma showing solid nests with
central comedo-type necrosis.
Figure 3. Salivary duct adenocarcinoma composed of small
infiltrating cords and ductular structures within dense fibrosis.
the same neoplasm. It must be differentiated from: (1)
synchronous tumours which are composed of histo-
logically distinct tumours presenting as separate
nodules;3,4 (2) malignancies arising from a pre-existing
benign tumour, as in carcinomas ex mixed tumour; or
(3) collision tumours in which two malignant tumours
abut each other but actually arise from separate
primary sites.
Hybrid tumours of the salivary gland are rare
neoplasms. Seifert reported five cases from over 6600
salivary gland tumours.1 The tumours arose in the
parotid gland, except in one case which involved
the palate. Three cases were malignant composed,
respectively, of acinic cell carcinoma and salivary
duct carcinoma; epithelial-myoepithelial carcinoma
and adenoid cystic carcinoma; basal cell adenoma and
adenoid cystic carcinoma. A hybrid carcinoma made
up of adenoid cystic carcinoma and salivary duct
adenocarcinoma has been documented in the palate.2
Our case had the same combination and similar
immunohistochemical findings but occurred in the
submandibular gland.
Salivary duct adenocarcinoma is a rare high-grade
neoplasm most commonly arising in the parotid gland.
Comedo-type necrosis is a common feature, with some
histological and immunohistochemical similarities to
ductal carcinoma of the breast.5 Salivary duct adeno-
carcinoma has an aggressive course with early, wide-
spread metastases.6
Adenoid cystic carcinoma most often involves the
parotid, submandibular gland and palate.7 As with
most salivary gland neoplasms, the tumour is slightly
more common in females than in males. Histologically,
a mixture of cribriform, tubular and solid patterns
may be seen. Some believe that adenoid cystic carcin-
oma with a solid growth pattern has a worse prog-
nosis.8 However histological grading of adenoid
cystic carcinoma is fraught with lack of reproduc-
ibility.9 Clinical stage appears to be the more signi-
ficant prognostic factor rather than the histological
subtype.10
Some features of adenoid cystic carcinoma and
salivary duct carcinoma may overlap. Necrosis may
occasionally be seen in the solid variant of adenoid
cystic carcinoma. The tubular pattern of adenoid cystic
carcinoma may simulate the infiltrating ductules of
salivary duct carcinoma. Perineural invasion can be
seen in both entities. Attention to cytological detail
helps in distinguishing the two tumours. The cells of
adenoid cystic carcinoma appear basaloid while those
of salivary duct adenocarcinoma are more pleomor-
phic accompanied by mitotic figures. Confirmation of
the two tumour lines in this case was made by using
immunohistochemical stains for actin, cytokeratin,
vimentin and S100. Expression of breast markers is
variable in salivary duct carcinoma.5 Stains for oestro-
gen receptors, progesterone receptors and BRST-2 were
negative in this case and were not useful as differential
markers.
Differentiating the two tumours is prognostically
important even if one believes that the solid variant
of adenoid cystic carcinoma has a worse prognosis
compared to the conventional cribriform subtype.
The 5-year survival rate for salivary duct adenocar-
cinoma is 30%, which is still more dismal than the
42% 5-year survival rate for the solid form of adenoid
cystic carcinoma.11,12
In conclusion, we report a hybrid carcinoma com-
posed of salivary duct adenocarcinoma and adenoid
cystic carcinoma. The origin of hybrid tumours is still
largely unknown. In our case, it may represent diverg-
ing differentiation of luminal tumour cells, with one
line exhibiting the features of salivary duct adenocar-
cinoma, while the other line the features of adenoid
cystic carcinoma. The lineage of each was confirmed by
immunohistochemistry. The behaviour of the tumour
is most consistent with the salivary duct carcinoma
component.
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